SCIENCE

NewLink Says Ebola Vaccine Trial Could Start In Weeks

ebola1
NewLink Genetics Corp, which licensed an Ebola vaccine developed by Canadian government scientists, has enough doses on hand to launch the first human safety trial of an Ebola vaccine this summer, its chief executive said on Wednesday.
More news

Pages

IBT Spotlight

We Help Businesses Find B2B Service Providers They Can Trust.